Top

Published in:

01-08-2006 | UPDATE

Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging

Authors: Emanuele Casciani, Gian Franco Gualdi

Published in: Abdominal Radiology | Issue 4/2006

Abstract

The results of recent studies of magnetic resonance imaging (MRI) combined with three-dimensional magnetic resonance spectroscopic imaging (3D-MRSI) demonstrate that the MRI/3D-MRSI exam is a unique method by which to noninvasively study the cellular metabolism and anatomy of the prostate. 3D-MRSI is emerging as the most specificity tool for non-invasive evaluation of the prostate cancer. The results of current MRI/3D-MRSI studies also provide evidence that the magnitude of metabolic changes in regions of cancer before therapy, as well as the extent of the time course of metabolic changes after therapy, may improve our understanding of cancer aggressiveness. Assessment of cancer spread outside the prostate can be significantly improved by combining MRI findings with estimates of metabolic abnormalities provided by 3D-MRSI. Clinically, combined MRI/3D-MRSI has already demonstrated a potential for improved diagnosis, staging, and treatment planning for patients with prostate cancer. This article reviewed the value of 3D-MRS imaging for the diagnosis, localization, staging, aggressiveness, and treatment planning of prostate cancer.

Jemal A, Murray T, Ward E, et al. (2005) Cancer statistics. CA Cancer J Clin 55:10–30PubMedCrossRef

Blute ML, Bergstralh EJ, Iocca A, et al. (2001) Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatectomy. J Urol 165:119–125PubMedCrossRef

Han M, Partin AW, Zahurak M, et al. (2003) Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 169:517–523PubMedCrossRef

Shipley WU, Thames HD, Sandler HM, et al. (1999) Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis. JAMA 281:1598–1604PubMedCrossRef

Sandler HM, Dunn RL, McLaughlin PW, et al. (2000) Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy. Int J Radiat Oncol Biol Phys 48:629–633PubMedCrossRef

Lu-Yao GL, Yao SL (1997) Population-based study of long-term survival in patients with clinically localised prostate cancer. Lancet 349:906–910PubMedCrossRef

Holmberg L, Bill-Axelson A, Helgensen F, et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 347:781–789PubMedCrossRef

Augustin H, Eggert T, Wenske S, et al. (2004) Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathologic stage in clinically localized prostate cancer. J Urol 171:177–181PubMedCrossRef

Cookson MS, Fleshner NE, Soloway SM, et al. (1997) Correlation between Gleason score of needle biopsy and radical prostatectomy specimens: accuracy and clinical implications. J Urol 157:559–562PubMedCrossRef

10.

Costello LC, Franklin RB (1991) Concepts of citrate production and secretion by prostate. I. Metabolic relationships. Prostate 18:25–46PubMedCrossRef

11.

Khan T, Beurrig K, Schmitz-Dreager B, et al. (1989) Prostatic carcinoma and benign prostatic hyperplasia. Radiology 173:847–851

12.

Costello LC, Franklin RB (1998) Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate 35:285–296PubMedCrossRef

13.

Liang JY, Liu YY, Zou J, et al. (1999) Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate 40:200–207PubMedCrossRef

14.

Rajesh A, Caokley FV (2004) MR imaging and MR spectroscopy imaging of prostate cancer. Magn Reson Imaging Clin North Am 12:557–579CrossRef

15.

Heston WD (1991) Prostatic polyamines and polyamine targeting as a new approach to therapy of prostatic cancer. Cancer Surv 11:217–238PubMed

16.

Kurhanewicz J, Vigneron DB, Hricak H, et al. (1996) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24–0.7-cm³) spatial resolution. Radiology 198:795–805PubMed

17.

Jung JA, Coakley FV, Vigneron DB, et al. (2004) Prostate depiction at endorectal mr spectroscopic imaging: investigation of a standardized evaluation system. Radiology 233:701–708PubMed

18.

Presti JC, Hricak H, Narayan PA, et al. (1996) Local staging of prostatic carcinoma: comparison of transrectal sonography and endorectal MR imaging. AJR 166:103–108PubMed

19.

Jager GJ, Ruijter ET, Van de Kaa CA, et al. (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR 166:845–852PubMed

20.

Hricak H, White S, Vigneron D, et al. (1994) Carcinoma of the prostate gland: MR imaging with pelvic phased-array coils versus integrated endorectal–pelvic phased-array coils. Radiology 193:703–709PubMed

21.

Schiebler M, Schnall MD, Pollack HM, et al. (1993) Current role of MR imaging in the staging of adenocarcinoma of the prostate. Radiology 189:339–352PubMed

22.

White S, Hricak H, Forstner R, et al. (1995) Prostate cancer: effect of postbiopsy haemorrhage on interpretation of MR images. Radiology 195:385–390PubMed

23.

Quint LE, Van Erp JS, Bland PH, et al. (1991) Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumour volume. AJR 156:511–516PubMed

24.

Scheidler J, Hricak H, Vigneron DB, et al. (1991) Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging–clinicopathologic study. Radiology 213:473–480

25.

Yu KK, Scheidler J, Hricak H, et al. (1999) Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology 213:481–488PubMed

26.

Wefer AE, Hricak H, Vigneron DB, et al. (2000) Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol 164:400–404PubMedCrossRef

27.

Casciani E, Polettini E, Pansadoro V, et al. (2005) Prostate cancer: evaluation with endorectal MR imaging and 3D proton MR spectroscopic imaging. Abstract. RSNA

28.

Kurhanewicz J, Vigneron DB, Males RG, et al. (2000) The prostate: MR imaging and spectroscopy-present and future. Radiol Clin North Am 38:115–138PubMedCrossRef

29.

Shukla-Dave Amita, Hedvig Hricak D, Eberhardt SC, et al. (2004) Chronic prostatitis: MR imaging and 1H MR spectroscopic imaging findings—initial observations. Radiology 231:717–724PubMed

30.

Casciani E, Polettini E, Bertini L, et al. (2005) Granulomatous prostatitis: a pitfall in endorectal MR imaging and 3D MR spectroscopic imaging. Eur J Radiol 54:111–114CrossRef

31.

Kaji Y, Kurhanewicz J, Hricak H, et al. (1998) Localizing prostate cancer in the presence of post-biopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology 206:785–790PubMed

32.

Prando A, Kurhanewicz J, Borges AP, et al. (2005) Prostatic biopsy directed with endorectal MR spectroscopic imaging findings in patients with elevated prostate specific antigen levels and prior negative biopsy findings: early experience. Radiology 236:903–910PubMed

33.

Yuen JS, Thng CH, Tan PH, et al. (2004) Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy. J Urol 171:1482–1486PubMedCrossRef

34.

Amsellem-Ouazana D, Younes P, Conquy S, et al. (2005) Negative prostatic biopsies in patients with High risk of prostate cancer. Eur Urol 47:582–586PubMedCrossRef

35.

Star-Lack J, Nelson SJ, Kurhanewicz J, et al. (1997) Improved water, lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 38:311–321PubMed

36.

Rifkin MD, Zerhouni EA, Gatsonis CA, et al. (1990) Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 323:621–626PubMedCrossRef

37.

Outwater EK, Petersen RO, Siegelman ES, et al. (1994) Prostate carcinoma: assessment of diagnostic criteria for capsular penetration on endorectal coil MR images. Radiology 193:333–339PubMed

38.

Tempany CM, Zhou X, Zerhouni EA, et al. (1994) Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. Radiology 192:47–54PubMed

39.

Harris RD, Schned AR, Heaney JA (1995) Staging of prostate cancer with endorectal MR imaging: lessons from a learning curve. RadioGraphics 15:813–829PubMed

40.

Jager JG, Ruijter ET, van de Kaa CA, et al. (1996) Local staging of prostate cancer with endorectal MR imaging: correlation with histopathology. AJR 166:845–850PubMed

41.

Ung JO, Richie JP, Chen MH, et al. (2002) Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 60:458–463PubMedCrossRef

42.

Ebstein J (1990) Evaluation of radical prostatectomy capsular margins of resection. Am J Surg Pathol 14:626–632PubMedCrossRef

43.

Wang L, Hricak H, Kattan KW, et al. (2006) Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 238:597–603PubMed

44.

Steinberg MD, Sauvageot J, Piantadosi S, et al. (1997) Correlation of prostate needle biopsy and radical prostatectomy Gleason grade in academic and community settings. Am J Surg Pathol 21:566–576PubMedCrossRef

45.

Zakian KL, Sircar K, Hricak H, et al. (2005) Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy. Radiology 234:804–814PubMed

46.

Kurhanewicz J, Vigneron DB, Hricak H, et al. (1996) Prostate cancer: metabolic response to cryosurgery as detected with 3D H-1 MR spectroscopic imaging. Radiology 200:489–496PubMed

47.

Parivar F, Hricak H, Shinohara K, et al. (1996) Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy. Urology 48:594–599PubMedCrossRef

48.

Kurhanewicz J, Vigneron DB, Males RG, et al. (2000) The prostate: magnetic resonance imaging and spectroscopy: present and future. In: Hricak H, Carroll PR, (eds). Radiological clinics of North America. Philadelphia: W.B. Saunders Co., pp 115–138

49.

Montironi R, Pomante R, Diamanti L, et al. (1998) Apoptosis in prostatic adenocarcinoma following complete androgen ablation. Urol Int 60:25–29PubMedCrossRef

50.

Mueller-Lisse UG, Swanson MG, Vigneron DB, et al. (2001) Hormone ablation of localized prostate cancer: time-dependent therapy effects on prostate metabolism detected by 3D 1H MR spectroscopy. Magn Reson Med 46:49–57PubMedCrossRef

51.

Coakley FV, Teh HS, Qayyum A, et al. (2004) Endorectal MR imaging and MR spectroscopic imaging for locally recurrent prostate cancer after external beam radiation therapy: preliminary experience. Radiology 233:441–448PubMed

Title: Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging
Authors: Emanuele Casciani
Gian Franco Gualdi
Publication date: 01-08-2006
Publisher: Springer-Verlag
Published in: Abdominal Radiology / Issue 4/2006
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI: https://doi.org/10.1007/s00261-006-9029-8

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Prostate cancer: value of magnetic resonance spectroscopy 3D chemical shift imaging

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2006

Gastrointestinal stromal tumors

Aneurysm of the inferior vena cava: case report

Transient small bowel intussusceptions: ultrasound findings and clinical significance

Sonoenteroclysis: a new technique for the diagnosis of small bowel diseases

Gallbladder adenoma: report of a case with emphasis on contrast-enhanced US findings

Bladder tumors: virtual MR cystoscopy

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page